English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background    Bordetella bronchiseptica  ( B.bronchiseptica ) is a frequent cause of respiratory infections in animals but rarely causes serious infection in humans. We present a rare case of  B. bronchiseptica  pneumonia in a patient with lung cancer.    Case presentation  A 52-year-old white male with non small cell lung cancer developed fever during treatment with nivolumab. A persistent productive cough and a deterioration in his clinical condition led to his hospitalization for evaluation. Bronchoscopy was performed and a diagnosis of  B. bronchiseptica  pneumonia was made. The infection was successfully managed by antiobiotic therapy.    Conclusions    B. bronchiseptica  is a pathogen that can cause serious infection in humans, especially in immunocompromised or immunoincompetent individuals. In our patient it showed unusual resistance to cephalosporins and poor sensitivity to amikacin. To our knowledge this is the first case of such an infection in a lung cancer patient undergoing treatment with nivolumab. When B . bronchiseptica  is identified, the possibility of a nosocomial transmission must be considered.

Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection